Robert W. Baird downgraded shares of CVS Health Corporation (NYSE:CVS) from an outperform rating to a neutral rating in a report issued on Thursday morning. The firm currently has $77.00 target price on the pharmacy operator’s stock, down from their prior target price of $86.00.
Several other equities analysts also recently weighed in on the stock. Vetr upgraded shares of CVS Health Corporation from a hold rating to a buy rating and set a $86.87 target price for the company in a research note on Monday, January 23rd. Guggenheim reiterated a buy rating and issued a $90.00 target price on shares of CVS Health Corporation in a research note on Wednesday, December 28th. Credit Suisse Group reaffirmed a buy rating on shares of CVS Health Corporation in a research note on Monday, December 19th. Oppenheimer Holdings, Inc. set a $88.00 price objective on shares of CVS Health Corporation and gave the company a buy rating in a research note on Sunday, December 18th. Finally, Jefferies Group LLC assumed coverage on shares of CVS Health Corporation in a research note on Monday, December 12th. They set a hold rating and a $82.00 price objective for the company. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. CVS Health Corporation has an average rating of Buy and a consensus price target of $100.27.